Cargando…

CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma

SIMPLE SUMMARY: CD229 is a cell-surface molecule predominantly expressed on lymphocytes. Its expression in B-cell malignancies is poorly known. We tested the presence of this immunoreceptor on a large number of malignancies and normal tissue using a new monoclonal antibody and tissue microarrays. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roncador, Giovanna, Puñet-Ortiz, Joan, Maestre, Lorena, Rodríguez-Lobato, Luis Gerardo, Jiménez, Scherezade, Reyes-García, Ana Isabel, García-González, Álvaro, García, Juan F., Piris, Miguel Ángel, Montes-Moreno, Santiago, Rodríguez-Justo, Manuel, Mena, Mari-Pau, Fernández de Larrea, Carlos, Engel, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101303/ https://www.ncbi.nlm.nih.gov/pubmed/35565280 http://dx.doi.org/10.3390/cancers14092154

Ejemplares similares

Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome
por: Puñet-Ortiz, Joan, et al.
Publicado: (2018)

High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations
por: Maestre, Lorena, et al.
Publicado: (2020)

Ly9 (CD229) Cell-Surface Receptor is Crucial for the Development of Spontaneous Autoantibody Production to Nuclear Antigens
por: de Salort, Jose, et al.
Publicado: (2013)

CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma
por: Martín-Moreno, Ana M., et al.
Publicado: (2015)

Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease
por: Isola, Ignacio, et al.
Publicado: (2021)

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
por: Rodríguez-Lobato, Luis Gerardo, et al.
Publicado: (2020)

First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
por: Oliver-Caldes, Aina, et al.
Publicado: (2021)

The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling
por: Díaz, Tania, et al.
Publicado: (2017)

Octupole correlations in $^{229}Ra$
por: Fraile-Prieto, L M, et al.
Publicado: (1999)

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features
por: Manso, Rebeca, et al.
Publicado: (2018)

On the nuclear structure of $^{229}$Ra
por: García-Borge, M J, et al.
Publicado: (1991)

Fatal human coronavirus 229E (HCoV-229E) and RSV–Related pneumonia in an AIDS patient from Colombia
por: Villamil-Gómez, Wilmer E., et al.
Publicado: (2020)

T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells
por: Battram, Anthony M., et al.
Publicado: (2022)

The nuclear structure of $^{229}$Th
por: Gulda, K, et al.
Publicado: (2002)

Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution
por: Jiménez-Segura, Raquel, et al.
Publicado: (2022)

Nuclear structure of $^{229}$Th
por: Ruchowska, E, et al.
Publicado: (2006)

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
por: Jian, Yuan, et al.
Publicado: (2016)

Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution
por: Rodríguez-Lobato, Luis Gerardo, et al.
Publicado: (2023)

A polymorphism in a phosphotyrosine signalling motif of CD229 (Ly9, SLAMF3) alters SH2 domain binding and T‐cell activation
por: Margraf, Stefanie, et al.
Publicado: (2015)

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide
por: Radhakrishnan, Sabarinath V., et al.
Publicado: (2020)

CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2022)

Correction for: CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2023)

Long-Term Responders After Autologous Stem Cell Transplantation in Multiple Myeloma
por: Oliver-Caldes, Aina, et al.
Publicado: (2022)

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
por: Luo, Linlin, et al.
Publicado: (2016)

Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
por: Moreno, David F., et al.
Publicado: (2021)

Computational Analysis of the Global Effects of Ly6E in the Immune Response to Coronavirus Infection Using Gene Networks
por: Delgado-Chaves, Fernando M., et al.
Publicado: (2020)

Autoimmune B Cell Repertoire in a Mouse Model of Sjögren’s Syndrome
por: Sáez Moya, Manuel, et al.
Publicado: (2021)

Health Tract, No. 229: Church Ventilation
Publicado: (1865)

The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever
por: Rodríguez-Lobato, Luis-Gerardo, et al.
Publicado: (2020)

Biomolecular functionalization for enhanced cell–material interactions of poly(methyl methacrylate) surfaces
por: Punet, Xavier, et al.
Publicado: (2015)

Developmental and communicative interrelations of Ly123 and Ly1 cell sets
Publicado: (1980)

Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina
por: Ottogalli, María Emilia, et al.
Publicado: (2021)

Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
por: Moreno, David F., et al.
Publicado: (2022)

Neces-SARI-ly?
por: Martin-Loeches, Ignacio, et al.
Publicado: (2016)

Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
por: Uribe-Herranz, Mireia, et al.
Publicado: (2021)

Talin variant P229S compromises integrin activation and associates with multifaceted clinical symptoms
por: Azizi, Latifeh, et al.
Publicado: (2022)

Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)
por: Parang, Keykavous, et al.
Publicado: (2020)

European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma
por: Bruno, Benedetto, et al.
Publicado: (2021)

B(E1) rates in $^{229}Ra$ and traces of octupole correlations at the upper border of the A=225 island
por: Fraile-Prieto, L M, et al.
Publicado: (1999)

P850: THE EFFECT OF UROLITHIN PRODUCTION BY GUT MICROBIOTA IN MULTIPLE MYELOMA
por: Rodríguez-García, Alba, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b1ait9td39bs8vf2ljllgm7ibn